Jeremy Curnock Cook - 12 Dec 2022 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
/s/ Donna Shiroma, by power of attorney
Issuer symbol
RCEL
Transactions as of
12 Dec 2022
Net transactions value
$0
Form type
4
Filing time
14 Dec 2022, 16:22:53 UTC
Previous filing
27 Dec 2021
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +12,589 +289% 16,939 12 Dec 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +5,395 $0.000000 5,395 12 Dec 2022 Common Stock 5,395 $6.95 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.
F2 Includes unvested RSUs.
F3 These Stock Options vest on the date 12 months following the grant date.